Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 2:57 pm Purchase | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 4,186,694 7.000% | 191,909 (+4.80%) | Filing History |
| 2024-11-14 1:28 pm Sale | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 1,765,042 2.900% | -2,224,788 (-55.76%) | Filing History |
| 2024-11-14 09:31 am Purchase | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Avoro Capital Advisors LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | Filing History |
| 2024-11-12 09:51 am Sale | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Artisan Partners Asset Management Inc. | 4,411,111 7.300% | -1,338,116 (-23.27%) | Filing History |
| 2024-11-08 10:34 am Sale | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Wellington Management Group LLP | 1,261,480 2.210% | -1,986,813 (-61.16%) | Filing History |
| 2024-02-16 4:29 pm Sale | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Associates, Inc. | 1,444,950 2.500% | -9,424,610 (-86.71%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 10,107,400 17.500% | 140,228 (+1.41%) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Baker Bros. Advisors LP | 0 0.000% | -4,954,855 (Position Closed) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 3,989,830 6.900% | 3,989,830 (New Position) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Associates, Inc. | 10,869,560 2.500% | 7,159,719 (+192.99%) | Filing History |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Avoro Capital Advisors LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing History |
| 2024-02-13 11:57 am Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 3,994,785 6.900% | 350,830 (+9.63%) | Filing History |
| 2024-02-12 06:12 am Sale | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Artisan Partners Asset Management Inc. | 5,749,227 10.000% | -1,171,129 (-16.92%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 5,114,369 9.067% | -114,701 (-2.19%) | Filing History |
| 2024-02-08 10:03 am Purchase | 2023-12-29 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Wellington Management Group LLP | 3,248,293 5.770% | 172,281 (+5.60%) | Filing History |
| 2024-02-02 1:18 pm Purchase | 2023-12-29 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.050% | 872,466 (+27.63%) | Filing History |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Baker Bros. Advisors LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Associates, Inc. | 3,709,841 6.500% | -1,051,352 (-22.08%) | Filing History |